var data={"title":"Standard immunizations for children and adolescents: Overview","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Standard immunizations for children and adolescents: Overview</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/contributors\" class=\"contributor contributor_credentials\">Jan E Drutz, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/contributors\" class=\"contributor contributor_credentials\">Teresa K Duryea, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/contributors\" class=\"contributor contributor_credentials\">Mary M Torchia, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 14, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Routine immunization schedules vary from country to country. This topic will provide an overview of immunization for children and adolescents in the United States. Immunization schedules for other countries are available through the <a href=\"http://apps.who.int/immunization_monitoring/globalsummary&amp;token=OwnNIPPeGk/rbsSIEMq0IgOjNOv7VUbbhIG6Z6gMcV0Dql41+3EEqSmN6lmXxVXDaQVNaZmvR6hPn+vQ/s4dzQ==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">World Health Organization</a>.</p><p>Detailed information about individual vaccines, vaccine refusal or hesitancy, and vaccination for adults is provided separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=hepatitis-b-virus-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">&quot;Hepatitis B virus immunization in infants, children, and adolescents&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=rotavirus-vaccines-for-infants\" class=\"medical medical_review\">&quot;Rotavirus vaccines for infants&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-infants-and-children-0-through-6-years-of-age\" class=\"medical medical_review\">&quot;Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=prevention-of-haemophilus-influenzae-type-b-infection\" class=\"medical medical_review\">&quot;Prevention of Haemophilus influenzae type b infection&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=pneumococcal-streptococcus-pneumoniae-conjugate-vaccines-in-children\" class=\"medical medical_review\">&quot;Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=poliovirus-vaccination\" class=\"medical medical_review\">&quot;Poliovirus vaccination&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention with vaccines&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=measles-mumps-and-rubella-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">&quot;Measles, mumps, and rubella immunization in infants, children, and adolescents&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=vaccination-for-the-prevention-of-chickenpox-primary-varicella-infection\" class=\"medical medical_review\">&quot;Vaccination for the prevention of chickenpox (primary varicella infection)&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=hepatitis-a-virus-infection-treatment-and-prevention\" class=\"medical medical_review\">&quot;Hepatitis A virus infection: Treatment and prevention&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-children-7-through-18-years-of-age\" class=\"medical medical_review\">&quot;Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=meningococcal-vaccines\" class=\"medical medical_review\">&quot;Meningococcal vaccines&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=human-papillomavirus-vaccination\" class=\"medical medical_review\">&quot;Human papillomavirus vaccination&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=standard-childhood-vaccines-parental-hesitancy-or-refusal\" class=\"medical medical_review\">&quot;Standard childhood vaccines: Parental hesitancy or refusal&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=standard-immunizations-for-nonpregnant-adults\" class=\"medical medical_review\">&quot;Standard immunizations for nonpregnant adults&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H81498659\"><span class=\"h1\">BENEFITS OF VACCINES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunization is one of the most effective preventive health measures (<a href=\"image.htm?imageKey=PEDS%2F58899\" class=\"graphic graphic_figure graphicRef58899 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The number of cases of most vaccine-preventable illnesses in the United States <a href=\"http://www.immunize.org/catg.d/p4037.pdf&amp;token=Xhpv4YrGbNrLf4iLM2FgO85KuGex52zEPqfPwjz7UAT2BXKEyFii9M9HjM4zDY0xrwC1JCwUsNIWoeWxLU0oqw==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">declined by more than 90 percent</a> after routine childhood immunizations were introduced.</p><p>Vaccination programs directly benefit the immunized child. They also indirectly benefit unimmunized persons through community (&quot;herd&quot;) immunity. Community immunity occurs when the portion of the population that is immune to the infection is large enough to decrease the risk of transmission [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/3,4\" class=\"abstract_t\">3,4</a>]. Community immunity protects children who are too young for immunization and persons with contraindications to vaccines. It relies on the majority of the population receiving routinely recommended immunizations. (See <a href=\"#H3968372383\" class=\"local\">'Vaccination coverage'</a> below.)</p><p class=\"headingAnchor\" id=\"H645243885\"><span class=\"h1\">ROUTINE SCHEDULE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The routine immunization schedules for children (<a href=\"image.htm?imageKey=PEDS%2F82617\" class=\"graphic graphic_figure graphicRef82617 \">figure 2A</a>) and adolescents (<a href=\"image.htm?imageKey=PEDS%2F58209\" class=\"graphic graphic_figure graphicRef58209 \">figure 2B</a>) in the United States are updated annually and collaboratively by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, the Committee on Infectious Diseases of the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Failure by health care providers, parents, and other caregivers to adhere to the recommended immunization schedules, including the timing of immunizations, leaves children susceptible to life-threatening vaccine-preventable diseases. (See <a href=\"topic.htm?path=standard-childhood-vaccines-parental-hesitancy-or-refusal#H16\" class=\"medical medical_review\">&quot;Standard childhood vaccines: Parental hesitancy or refusal&quot;, section on 'Consequences of vaccine refusal'</a>.)</p><p class=\"headingAnchor\" id=\"H3167808447\"><span class=\"h2\">Infants and children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Immunizations that are routinely recommended for infants and children in the United States are usually administered at health supervision visits (<a href=\"image.htm?imageKey=PEDS%2F82617\" class=\"graphic graphic_figure graphicRef82617 \">figure 2A</a>). However, every visit provides an opportunity to update vaccines. Multiple injections are required at most visits. The use of combination vaccines (eg, diphtheria, tetanus, acellular pertussis <span class=\"nowrap\">(DTaP)/hepatitis</span> B <span class=\"nowrap\">(HepB)/inactivated</span> <a href=\"topic.htm?path=poliovirus-vaccine-inactivated-pediatric-drug-information\" class=\"drug drug_pediatric\">poliovirus vaccine</a> (IPV) [Pediarix]; <span class=\"nowrap\">DTaP/<em>Haemophilus</span> influenzae</em> type b <span class=\"nowrap\">(Hib)/IPV</span> [Pentacel]; measles, mumps, and rubella <span class=\"nowrap\">(MMR)/varicella</span> [ProQuad]; and <span class=\"nowrap\">DTaP/IPV</span> [Kinrix]) can help to reduce the number of injections at each visit and improve vaccination coverage [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/6-9\" class=\"abstract_t\">6-9</a>].</p><p>Immunizations routinely recommended for infants and children in the United States include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5\" class=\"abstract_t\">5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis B vaccine</strong> &ndash; HepB vaccine is routinely recommended within 24 hours of birth, at age 1 through 2 months, and at age 6 through 12 months (<a href=\"image.htm?imageKey=PEDS%2F76345%7EPEDS%2F55139\" class=\"graphic graphic_table graphicRef76345 graphicRef55139 \">table 1A-B</a>). HepB vaccine is inactivated. It is administered intramuscularly (IM).</p><p/><p class=\"bulletIndent1\">Immunization against hepatitis B virus for infants, children, and adolescents is discussed in detail separately. (See <a href=\"topic.htm?path=hepatitis-b-virus-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">&quot;Hepatitis B virus immunization in infants, children, and adolescents&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Rotavirus vaccine</strong> &ndash; The routine schedule for <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> depends upon the vaccine formulation (<a href=\"image.htm?imageKey=PEDS%2F70478\" class=\"graphic graphic_table graphicRef70478 \">table 2</a>).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The pentavalent human-bovine rotavirus reassortant vaccine (RV5) is administered at 2, 4, and 6 months of age.</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The attenuated human <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> (RV1) is administered at 2 and 4 months of age.</p><p/><p class=\"bulletIndent1\">Both rotavirus vaccines are live attenuated viral vaccines. They are administered orally.</p><p/><p class=\"bulletIndent1\">Rotavirus immunization is discussed in detail separately. (See <a href=\"topic.htm?path=rotavirus-vaccines-for-infants\" class=\"medical medical_review\">&quot;Rotavirus vaccines for infants&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Diphtheria, tetanus, <span class=\"nowrap\">and/or</span> pertussis vaccines</strong> &ndash; DTaP vaccine is routinely recommended for infants and children at ages 2 months, 4 months, 6 months, 15 through 18 months, and 4 through 6 years. Booster doses are required beginning at age 11 years. DTaP vaccine is an inactivated vaccine. It is administered IM.</p><p/><p class=\"bulletIndent1\">Diphtheria, tetanus, and pertussis immunization for children is discussed in detail separately. (See <a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-infants-and-children-0-through-6-years-of-age\" class=\"medical medical_review\">&quot;Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>H. influenzae</em></strong><strong> type b conjugate vaccine</strong> &ndash; Hib conjugate vaccine is routinely recommended in a two- or three-dose primary series (at age 2 and 4 months or at age 2, 4, and 6 months, depending upon the vaccine formulation) with a booster dose at age 12 through 15 months (<a href=\"image.htm?imageKey=ID%2F77170\" class=\"graphic graphic_table graphicRef77170 \">table 3</a>). Hib vaccines are inactivated vaccines. They are administered IM.</p><p/><p class=\"bulletIndent1\">Hib immunization is discussed in detail separately. (See <a href=\"topic.htm?path=prevention-of-haemophilus-influenzae-type-b-infection#H2\" class=\"medical medical_review\">&quot;Prevention of Haemophilus influenzae type b infection&quot;, section on 'Routine childhood immunization in the US'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pneumococcal conjugate vaccine</strong> &ndash; The <a href=\"topic.htm?path=pneumococcal-conjugate-vaccine-13-valent-pediatric-drug-information\" class=\"drug drug_pediatric\">13-valent pneumococcal conjugate vaccine</a> (PCV13) is routinely recommended at age 2, 4, 6, and 12 through 15 months. PCV13 is an inactivated vaccine. It is administered IM.</p><p/><p class=\"bulletIndent1\">Pneumococcal immunization for children is discussed in detail separately. (See <a href=\"topic.htm?path=pneumococcal-streptococcus-pneumoniae-conjugate-vaccines-in-children\" class=\"medical medical_review\">&quot;Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Inactivated </strong><strong>poliovirus vaccine</strong> &ndash; IPV is routinely recommended at age 2 months, 4 months, 6 through 18 months, and 4 through 6 years (<a href=\"image.htm?imageKey=ID%2F78224\" class=\"graphic graphic_table graphicRef78224 \">table 4</a>). IPV is administered IM or subcutaneously.</p><p/><p class=\"bulletIndent1\">Poliovirus immunization is discussed in detail separately. (See <a href=\"topic.htm?path=poliovirus-vaccination\" class=\"medical medical_review\">&quot;Poliovirus vaccination&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Influenza vaccine </strong>&ndash; Influenza immunization is recommended annually for all children &ge;6 months of age, particularly those at high risk for complications (<a href=\"image.htm?imageKey=PEDS%2F72029\" class=\"graphic graphic_table graphicRef72029 \">table 5</a>). Inactivated influenza vaccines (IIV) for children &lt;18 years are administered IM (<a href=\"image.htm?imageKey=ID%2F79474\" class=\"graphic graphic_table graphicRef79474 \">table 6</a>). The <a href=\"topic.htm?path=influenza-virus-vaccine-live-attenuated-pediatric-drug-information\" class=\"drug drug_pediatric\">live attenuated influenza vaccine</a> (LAIV) is administered intranasally. For the 2017-2018 influenza season in the United States, LAIV is not recommended [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/10\" class=\"abstract_t\">10</a>].</p><p/><p class=\"bulletIndent1\">Influenza immunization in children is discussed in detail separately. (See <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention with vaccines&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Measles, mumps, and rubella vaccine</strong> &ndash; MMR vaccine is routinely recommended at age 12 through 15 months and age 4 through 6 years. MMR is a live attenuated virus vaccine. It is administered subcutaneously.</p><p/><p class=\"bulletIndent1\">Immunization against measles, mumps, and rubella is discussed in detail separately. (See <a href=\"topic.htm?path=measles-mumps-and-rubella-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">&quot;Measles, mumps, and rubella immunization in infants, children, and adolescents&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Varicella vaccine</strong> &ndash; Varicella-zoster virus (VZV; chickenpox) vaccine is routinely recommended at age 12 through 15 months and age 4 through 6 years. VZV vaccine is a live attenuated virus vaccine. It is administered subcutaneously.</p><p/><p class=\"bulletIndent1\">Immunization against varicella-zoster virus is discussed in detail separately. (See <a href=\"topic.htm?path=vaccination-for-the-prevention-of-chickenpox-primary-varicella-infection\" class=\"medical medical_review\">&quot;Vaccination for the prevention of chickenpox (primary varicella infection)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis A vaccine</strong> &ndash; Two doses of hepatitis A virus (HepA) vaccine are routinely recommended between 12 and 24 months; the doses should be separated by at least six months [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/11\" class=\"abstract_t\">11</a>]. HepA vaccine is an inactivated vaccine. It is administered IM.</p><p/><p class=\"bulletIndent1\">Immunization against hepatitis A virus is discussed in detail separately. (See <a href=\"topic.htm?path=hepatitis-a-virus-infection-treatment-and-prevention\" class=\"medical medical_review\">&quot;Hepatitis A virus infection: Treatment and prevention&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4095257626\"><span class=\"h2\">Adolescents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most of the immunizations that are routinely recommended for adolescents in the United States are administered at 11 through 12 years or 16 years of age (<a href=\"image.htm?imageKey=PEDS%2F58209\" class=\"graphic graphic_figure graphicRef58209 \">figure 2B</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5,12\" class=\"abstract_t\">5,12</a>]. However, every visit provides an opportunity to update <span class=\"nowrap\">and/or</span> complete an adolescent's immunizations [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/13,14\" class=\"abstract_t\">13,14</a>]. (See <a href=\"#H3005310320\" class=\"local\">'Catch-up schedule'</a> below.)</p><p>Immunizations that are routinely recommended for adolescents in the United States include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5\" class=\"abstract_t\">5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tetanus, diphtheria, and acellular pertussis vaccine</strong> &ndash; A single dose of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine is routinely recommended at age 11 through 12 years. Tdap is an inactivated vaccine. It is administered IM.</p><p/><p class=\"bulletIndent1\">Immunization against tetanus, diphtheria, and pertussis for older children and adolescents is discussed in detail separately. (See <a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-children-7-through-18-years-of-age\" class=\"medical medical_review\">&quot;Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Meningococcal vaccines</strong> &ndash; Quadrivalent meningococcal conjugate vaccine (MCV4) is routinely recommended at age 11 through 12 years and at age 16 years. MCV4 is an inactivated vaccine. It is administered IM.</p><p/><p class=\"bulletIndent1\">Meningococcal serogroup B vaccines are not routinely recommended for adolescents who are not at increased risk for meningococcal disease. However, they may be given to adolescents and young adults age 16 through 23 years (age 16 through 18 years is preferred) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p class=\"bulletIndent1\">Immunization against meningococcal disease is discussed in detail separately. (See <a href=\"topic.htm?path=meningococcal-vaccines#H20\" class=\"medical medical_review\">&quot;Meningococcal vaccines&quot;, section on 'Age 11 to 18 years'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Human papillomavirus vaccine </strong>&ndash; Two doses of the 9-valent human papillomavirus (HPV) vaccine are routinely recommended for immune-competent adolescents 11 through 12 years of age; the doses should be separated by at least six months [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5,16,17\" class=\"abstract_t\">5,16,17</a>].</p><p/><p class=\"bulletIndent1\">If the adolescent is immunocompromised or the HPV vaccine series is initiated at &ge;15 years of age, three doses of HPV vaccine are recommended; the second dose should be given one to two months after the first dose; the third dose should be given six months after the first dose. (See <a href=\"topic.htm?path=human-papillomavirus-vaccination#H4094871935\" class=\"medical medical_review\">&quot;Human papillomavirus vaccination&quot;, section on 'Indications and age range'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Influenza vaccine</strong> &ndash; Influenza immunization is recommended annually for all children &ge;6 months of age, particularly those at high risk for complications (<a href=\"image.htm?imageKey=PEDS%2F72029\" class=\"graphic graphic_table graphicRef72029 \">table 5</a>). IIV for children are administered IM. LAIV is administered intranasally. For the 2017-2018 influenza season in the United States, LAIV is not recommended [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention with vaccines&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3005310320\"><span class=\"h1\">CATCH-UP SCHEDULE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children who are behind on vaccines should be caught up using the minimum intervals between doses (<a href=\"image.htm?imageKey=PEDS%2F58271%7EPEDS%2F72079\" class=\"graphic graphic_table graphicRef58271 graphicRef72079 \">table 7A-B</a>). It is not necessary to restart the series &ndash; even when the interval between doses is prolonged [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,18\" class=\"abstract_t\">14,18</a>].</p><p>The Centers for Disease Control and Prevention has developed &quot;job aids&quot; to provide guidance for catch-up of individual vaccines:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.cdc.gov/vaccines/schedules/downloads/child/job-aids/pneumococcal.pdf&amp;token=tOdEoTf5ljtGtizH0uwcXEKM5gSRP2vrRdxpzqImsy7aSzJPolEa7Q/JQT45HcKqboS2FnKkHm4aPaLGyja/sPGJiuxYmPkD4WPrG7e+rMo=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Pneumococcal conjugate vaccine</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>H. influenzae</em> type b (Hib)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"https://www.cdc.gov/vaccines/schedules/downloads/child/job-aids/hib-actHib.pdf&amp;token=OB1/tTh/b3Dl8verH6gfaCtENVJJgiToUBCZTdAjOoPIbQfvgddoKt7x+WD2BpqybLlAJeISBqHRd+vZOdgkR3XzNjQjikJ39dDw2R5bseY=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Previous immunization with ActHiB, Pentacel, Menhibrix (discontinued in 2016), or unknown Hib vaccine</a></p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"https://www.cdc.gov/vaccines/schedules/downloads/child/job-aids/hib-pedvax.pdf&amp;token=N+vlL8QThFnePHKsoQZRmAZ7+55YAU2KEyW88UJFW7wOC8ZT1aBrehqifvIkGKGB/DPb1V41D5JUaAQLgQmZuNOWJW0+cb5dqdWVVyzrbLU=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Previous immunization with PedVaxHIB or Comvax (discontinued in 2014)</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.cdc.gov/vaccines/schedules/downloads/child/job-aids/dtap.pdf&amp;token=tOdEoTf5ljtGtizH0uwcXFuJNNpgpl1WuO1vtEtc55yzZoInNMcBIBX4q1qHKaWwgtKS8lcCoRpV/KpaijDWLAgYjp2Kbo4rvaSUVWNsaN0=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Diphtheria, tetanus, and pertussis-containing vaccines</a></p><p/><p class=\"headingAnchor\" id=\"H359865919\"><span class=\"h1\">VACCINE HESITANCY OR REFUSAL</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to parents who are hesitant to have their child vaccinated or refuse childhood vaccines is discussed separately. (See <a href=\"topic.htm?path=standard-childhood-vaccines-parental-hesitancy-or-refusal#H19\" class=\"medical medical_review\">&quot;Standard childhood vaccines: Parental hesitancy or refusal&quot;, section on 'Approach to management'</a>.)</p><p class=\"headingAnchor\" id=\"H442888927\"><span class=\"h1\">OTHER SPECIAL CIRCUMSTANCES</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preterm infants </strong>&ndash; The routine immunization schedule, dose, intervals, and <span class=\"nowrap\">contraindications/precautions</span> are the same for preterm infants (born at &lt;37 weeks' gestation) as for infants and children who were born at &ge;37 weeks' gestation, with the exception of hepatitis B (HepB) vaccine [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>]. For infants who weigh &lt;2 kg (4.4 pounds) at birth <strong>and</strong> are born to women who are hepatitis B surface antigen negative, the first dose of HepB vaccine is postponed until hospital discharge or 30 days of age, whichever is earlier (<a href=\"image.htm?imageKey=PEDS%2F55139\" class=\"graphic graphic_table graphicRef55139 \">table 1B</a>). (See <a href=\"topic.htm?path=hepatitis-b-virus-immunization-in-infants-children-and-adolescents#H548176156\" class=\"medical medical_review\">&quot;Hepatitis B virus immunization in infants, children, and adolescents&quot;, section on 'Routine infant immunization'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immune-compromised children </strong>&ndash;<strong> </strong>Immunization of children with primary immunodeficiency, <span class=\"nowrap\">asplenia/hyposplenia,</span> and human immunodeficiency virus (HIV) discussed separately. (See <a href=\"topic.htm?path=immunizations-in-patients-with-primary-immunodeficiency\" class=\"medical medical_review\">&quot;Immunizations in patients with primary immunodeficiency&quot;</a> and <a href=\"topic.htm?path=prevention-of-sepsis-in-the-asplenic-patient#H4\" class=\"medical medical_review\">&quot;Prevention of sepsis in the asplenic patient&quot;, section on 'Immunizations'</a> and <a href=\"topic.htm?path=immunizations-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Immunizations in HIV-infected patients&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Specific caveats regarding immunization in children with secondary immunodeficiency (eg, high-dose glucocorticoids) are discussed in topics related to individual vaccines. For example, (see <a href=\"topic.htm?path=measles-mumps-and-rubella-immunization-in-infants-children-and-adolescents#H1787928363\" class=\"medical medical_review\">&quot;Measles, mumps, and rubella immunization in infants, children, and adolescents&quot;, section on 'Contraindications'</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Close contacts of immune-compromised persons</strong> &ndash; Close (eg, household) contacts of immune-compromised persons should receive all routinely recommended vaccines (<a href=\"image.htm?imageKey=PEDS%2F82617%7EPEDS%2F58209\" class=\"graphic graphic_figure graphicRef82617 graphicRef58209 \">figure 2A-B</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>]. Close contacts of immunocompromised persons should not receive <a href=\"topic.htm?path=smallpox-vaccine-united-states-availability-limited-to-cdc-distribution-from-strategic-national-stockpile-in-consultation-with-local-health-department-drug-information\" class=\"drug drug_general\">smallpox vaccine</a>, which is not routinely recommended for children or adolescents. (See <a href=\"topic.htm?path=vaccinia-virus-as-the-smallpox-vaccine#H13\" class=\"medical medical_review\">&quot;Vaccinia virus as the smallpox vaccine&quot;, section on 'Contraindications'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Children and adolescents with increased risk of bleeding</strong> &ndash; For children and adolescents at increased risk of bleeding following intramuscular (IM) injections, we suggest consultation with the child's hematologist. The Advisory Committee on Immunization Practices best practice guidelines indicate that IM injections can be administered to a child or adolescent with a bleeding disorder if a clinician familiar with the patient's bleeding risk determines that the vaccine can be administered with reasonable safety [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>]. Additional suggestions include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,19\" class=\"abstract_t\">14,19</a>]:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>If possible, schedule IM injections shortly after administration of clotting factors or before administration of anticoagulant medications</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Use a 23-gauge or smaller caliber needle</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Apply firm pressure on the site, without rubbing, for at least two minutes after injection</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pregnant adolescents</strong> &ndash; Live vaccines (eg, measles, mumps, and rubella [MMR] vaccine, <a href=\"topic.htm?path=varicella-virus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">varicella vaccine</a>, MMR-varicella vaccine) and human papillomavirus vaccine should be avoided during pregnancy. The approach to immunizations during pregnancy is discussed separately. (See <a href=\"topic.htm?path=immunizations-during-pregnancy\" class=\"medical medical_review\">&quot;Immunizations during pregnancy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Children or close contacts of pregnant women</strong> &ndash; Children and close contacts of pregnant women should receive routinely recommended vaccines, including live virus vaccines (eg, MMR vaccine, <a href=\"topic.htm?path=varicella-virus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">varicella vaccine</a>, <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Recent or anticipated administration of </strong><strong>immune globulin</strong><strong> or blood products</strong> &ndash; MMR and varicella vaccines should not be administered on the same day as <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-pediatric-drug-information\" class=\"drug drug_pediatric\">immune globulin</a> or for several months after immune globulin or blood products (<a href=\"image.htm?imageKey=PEDS%2F72640\" class=\"graphic graphic_table graphicRef72640 \">table 8</a>). Immune globulin and blood products contain antibodies, which can interfere with the vaccine response.</p><p/><p class=\"bulletIndent1\">If <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-pediatric-drug-information\" class=\"drug drug_pediatric\">immune globulin</a> or blood products must be given within 14 days after administration of MMR or <a href=\"topic.htm?path=varicella-virus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">varicella vaccine</a>, another dose of the vaccine should be administered after the suggested interval (<a href=\"image.htm?imageKey=PEDS%2F72640\" class=\"graphic graphic_table graphicRef72640 \">table 8</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immunizations for travel</strong> &ndash; Immunizations for travel are discussed separately. (See <a href=\"topic.htm?path=immunizations-for-travel\" class=\"medical medical_review\">&quot;Immunizations for travel&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Children vaccinated outside the United States</strong> &ndash; The approach to immunization of children who were vaccinated outside the United States is the same as that for internationally adopted children. It is discussed separately. (See <a href=\"topic.htm?path=international-adoption-immunization-considerations\" class=\"medical medical_review\">&quot;International adoption: Immunization considerations&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3599497874\"><span class=\"h1\">VACCINE ADMINISTRATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The Advisory Committee on Immunization Practices (ACIP) provides best practice recommendations for vaccine administration, including <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01&amp;token=6ueO/axldHJpCyCaCNPb7uMqEZnReO+F5bq+/YAxewNZACeP57Tnw+NHc51meqNsV41MTsQnMRg053ZFXysw5aVGxhL1u1QTvFDjcP9yC40=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">minimum ages and intervals between vaccine doses</a>, as well as the recommended dose, route, and site of administration for individual vaccines (<a href=\"image.htm?imageKey=PEDS%2F114641\" class=\"graphic graphic_table graphicRef114641 \">table 9</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>]. Variations from these recommendations may result in invalid doses. (See <a href=\"#H1227501216\" class=\"local\">'Invalid doses'</a> below.)</p><p class=\"headingAnchor\" id=\"H1184246441\"><span class=\"h2\">Preadministration counseling</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the United States, the National Childhood Vaccine Injury Act requires clinicians to provide the relevant vaccine information statement(s) to the child's <span class=\"nowrap\">caregiver/legal</span> guardian before vaccine administration. <a href=\"https://www.cdc.gov/vaccines/hcp/vis/current-vis.html&amp;token=R4Uiw8/bmPVaqNHRDqpXLAH/K5ePuSCWLS93Qnaa3r/5qdQw/NYQGK1y+HqFU7TkRZLnBxvqrSwSUrCQcXZVSA==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Vaccine information statements</a> are available from the Centers for Disease Control and Prevention (CDC).</p><p>The <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html#t-01&amp;token=6ueO/axldHJpCyCaCNPb7mHVrSmDPVTmUZqlyjUwPWA2E+zSFV1qRAZwVZzcsMt7hVW5Sj+7i39F1S9Glgtnx1GqqYVj+NHr5juvqXVbacY=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">CDC website</a> provides a list of contraindications and precautions to vaccines commonly used for children and adolescents. The <a href=\"http://www.immunize.org/clinic/screening-contraindications.asp&amp;token=RMVe12SjWg+4o2Kds27YUnrCntJy16KtlHqVDpCxxn0ZMpyPUZQbw+Yo4ms7zN/ID5FgQucatkitGzJ4qBS4+BG63+5ptk287rcvs0KmGys=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Immunization Action Coalition</a> website provides screening checklists for contraindications or precautions. Contraindications and precautions for specific vaccines and combination vaccines are discussed in individual topics related to immunizations for children.</p><p>Educating <span class=\"nowrap\">parents/caregivers</span> and patients about vaccine-related pain management may be helpful in reducing pain during and after injections [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"#H397633702\" class=\"local\">'Reducing injection pain'</a> below.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Injectable vaccines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most of the routinely recommended childhood vaccines are injected intramuscularly (IM) or subcutaneously (<a href=\"image.htm?imageKey=PEDS%2F114641\" class=\"graphic graphic_table graphicRef114641 \">table 9</a>). The preferred position of the child and site of injection vary with age and route of injection (<a href=\"image.htm?imageKey=PEDS%2F114644\" class=\"graphic graphic_table graphicRef114644 \">table 10</a>). The injection site should be as free as possible from risk of local neural, vascular, or tissue injury [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,21\" class=\"abstract_t\">14,21</a>].</p><p class=\"headingAnchor\" id=\"H3928209354\"><span class=\"h3\">Patient position</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Infants &lt;12 months</strong> &ndash; Infants &lt;12 months usually are held by their caregiver during injections; skin-to-skin contact is preferred for infants younger than one month [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/22\" class=\"abstract_t\">22</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>12 months through 2 years</strong> &ndash; Children 12 months through 2 years usually are held by their caregiver during injections (<a href=\"image.htm?imageKey=PEDS%2F114649\" class=\"graphic graphic_figure graphicRef114649 \">figure 3</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>3 years and older</strong> &ndash; Children 3 years through 11 years usually are seated during injections; they may be held by their caregiver. Adolescents &ge;12 years and young adults may be seated or lying down during injections [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>].</p><p/><p class=\"headingAnchor\" id=\"H1833949965\"><span class=\"h3\">Immunization technique</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Injectable vaccines should be administered using sterile technique [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,21\" class=\"abstract_t\">14,21</a>]. It is not necessary to change needles between drawing the vaccine into the syringe and injecting it. A new needle and a new syringe should be used for each injection.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intramuscular injection</strong> &ndash; The preferred site for IM injections varies with age:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Infants &lt;12 months &ndash; Anterolateral thigh (vastus lateralis) (<a href=\"image.htm?imageKey=PEDS%2F114647\" class=\"graphic graphic_figure graphicRef114647 \">figure 4</a>) is preferred; if the anterolateral thigh cannot be used (eg, because it is covered by a cast), the ventrogluteal site (<a href=\"image.htm?imageKey=PEDS%2F114650\" class=\"graphic graphic_figure graphicRef114650 \">figure 5</a>) can be used; the upper outer gluteal quadrant (the dorsogluteal site) of the buttock should be avoided because of the possibility of a suboptimal immune response [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/23,24\" class=\"abstract_t\">23,24</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>12 months through 2 years &ndash; Anterolateral thigh is preferred, but the deltoid area of upper arm may be used.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&ge;3 years &ndash; Deltoid area of upper arm (<a href=\"image.htm?imageKey=PEDS%2F114648\" class=\"graphic graphic_figure graphicRef114648 \">figure 6</a>).</p><p/><p class=\"bulletIndent1\">The suggested needle length and gauge varies with age, sex, and weight (<a href=\"image.htm?imageKey=PEDS%2F60863\" class=\"graphic graphic_table graphicRef60863 \">table 11</a>). The needles should be long enough to reach the muscle but not so long as to penetrate underlying nerves, blood vessels, or bone [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,21,25-29\" class=\"abstract_t\">14,21,25-29</a>]. Penetration into the bone can cause pain, damage to the periosteum, and detachment of the needle from the syringe [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p class=\"bulletIndent1\">The angle between the needle and the skin should be 90&deg;. It is not necessary to pull back on the syringe plunger after needle insertion before IM injection [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,31\" class=\"abstract_t\">14,31</a>]. The recommended sites for IM injections do not contain large blood vessels, and aspiration before injection may increase injection pain [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,22,32,33\" class=\"abstract_t\">20,22,32,33</a>].</p><p/><p class=\"bulletIndent1\">For deltoid injections, in addition to using the appropriate size needle, the following steps should be taken to avoid inadvertent injection into the subdeltoid bursa or joint space, which may cause &quot;shoulder injury related to vaccine administration&quot; [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/34-36\" class=\"abstract_t\">34-36</a>] (see <a href=\"#H3715912941\" class=\"local\">'Local and systemic reactions'</a> below):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Both the patient and the vaccinator should be seated.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The arm should be completely exposed and lifted slightly out to the side (eg, with the hand placed on the ipsilateral hip), which causes the subdeltoid bursa to slide under the acromion for protection.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The needle should be inserted into the center of the deltoid muscle, midway between the acromion and the deltoid tuberosity (the insertion of the deltoid at the middle of the humerus), a point that falls in the middle one-third of an inverted triangle between the acromion and the deltoid tuberosity (<a href=\"image.htm?imageKey=PEDS%2F114648\" class=\"graphic graphic_figure graphicRef114648 \">figure 6</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Subcutaneous injection</strong> &ndash; The preferred site for subcutaneous injections varies with age:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Infants &lt;12 months &ndash; The fatty tissue over the anterolateral thigh is preferred (<a href=\"image.htm?imageKey=PEDS%2F114647\" class=\"graphic graphic_figure graphicRef114647 \">figure 4</a>); the upper-outer triceps may be used if necessary.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>&ge;12 months &ndash; The fatty tissue over the upper-outer area of triceps is preferred.</p><p/><p class=\"bulletIndent1\">For subcutaneous injections, a 23- or 25-gauge needle <span class=\"nowrap\">5/8</span> inch (16 mm) long is recommended [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/21\" class=\"abstract_t\">21</a>]. The angle between the needle and skin should be 45&deg;.</p><p/><p class=\"headingAnchor\" id=\"H416059916\"><span class=\"h2\">Oral vaccines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rotavirus is the only routine childhood vaccine that is administered orally. Administration of <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> is discussed separately. (See <a href=\"topic.htm?path=rotavirus-vaccines-for-infants#H3803151\" class=\"medical medical_review\">&quot;Rotavirus vaccines for infants&quot;, section on 'Administration'</a>.)</p><p class=\"headingAnchor\" id=\"H680783462\"><span class=\"h2\">Intranasal vaccines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <a href=\"topic.htm?path=influenza-virus-vaccine-live-attenuated-pediatric-drug-information\" class=\"drug drug_pediatric\">live attenuated influenza vaccine</a> (LAIV) is the only routine childhood vaccine that is administered intranasally; an <a href=\"topic.htm?path=influenza-virus-vaccine-inactivated-pediatric-drug-information\" class=\"drug drug_pediatric\">inactivated influenza vaccine</a> that is administered IM is an alternative to intranasal injection. Indications for and administration of LAIV are discussed separately. (See <a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines#H2192484719\" class=\"medical medical_review\">&quot;Seasonal influenza in children: Prevention with vaccines&quot;, section on 'Route and dose'</a>.)</p><p class=\"headingAnchor\" id=\"H2561276728\"><span class=\"h2\">Administration of multiple vaccines at one visit</span></p><p class=\"headingAnchor\" id=\"H2672370466\"><span class=\"h3\">Timing and spacing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no upper limit to the number of vaccines that may be administered at a single visit [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,18,37\" class=\"abstract_t\">14,18,37</a>]. The vaccines should not be mixed in the same syringe unless the combination has been specifically approved by the US Food and Drug Administration.</p><p>Most <strong>routine</strong> vaccines for children and adolescents (<a href=\"image.htm?imageKey=PEDS%2F82617%7EPEDS%2F58209\" class=\"graphic graphic_figure graphicRef82617 graphicRef58209 \">figure 2A-B</a>) can be administered on the same day (at different sites) without compromising effectiveness [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,38-43\" class=\"abstract_t\">14,38-43</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Two or more <strong>inactivated</strong> vaccines may be administered at the same visit or at any interval between doses with two exceptions:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In persons with functional or anatomic asplenia, the <a href=\"topic.htm?path=pneumococcal-conjugate-vaccine-13-valent-pediatric-drug-information\" class=\"drug drug_pediatric\">13-valent pneumococcal conjugate vaccine</a> (PCV13) should be given at least 28 days before the Menactra quadrivalent meningococcal conjugate vaccine. (See <a href=\"topic.htm?path=prevention-of-sepsis-in-the-asplenic-patient#H8\" class=\"medical medical_review\">&quot;Prevention of sepsis in the asplenic patient&quot;, section on 'Meningococcal vaccine'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>In persons who require both PCV13 and the 23-valent <a href=\"topic.htm?path=pneumococcal-polysaccharide-vaccine-23-valent-pediatric-drug-information\" class=\"drug drug_pediatric\">pneumococcal polysaccharide vaccine</a> (PPSV23), PCV13 should be administered at least eight weeks before PPSV23.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Inactivated</strong> and <strong>live vaccines</strong> (<a href=\"image.htm?imageKey=ID%2F112956\" class=\"graphic graphic_table graphicRef112956 \">table 12</a>) may be administered at the same visit or at any interval between doses.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Two or more <strong>live</strong> <strong>injectable </strong>vaccines (eg, measles, mumps, and rubella [MMR] vaccine and <a href=\"topic.htm?path=varicella-virus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">varicella vaccine</a>) (<a href=\"image.htm?imageKey=ID%2F112956\" class=\"graphic graphic_table graphicRef112956 \">table 12</a>) may be administered on the same day or &ge;28 days apart. Live oral <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> and live oral <a href=\"topic.htm?path=typhoid-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">typhoid vaccine</a> may be administered on the same day as or at any interval before inactivated or live injectable vaccines.</p><p/><p class=\"headingAnchor\" id=\"H2827536485\"><span class=\"h3\">Site of injections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When multiple injectable vaccines are required at a single visit, separate limbs should be used if possible, particularly for injections more likely to cause a local reaction (eg, diphtheria, tetanus, acellular pertussis vaccine and PCV13) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,21,37\" class=\"abstract_t\">14,21,37</a>]. If necessary, two or more vaccines can be given in the same limb (usually the anterolateral thigh). If possible, the injections should be separated by at least 2.5 cm (1 inch) to avoid overlap of local reactions.</p><p>If a vaccine and <a href=\"topic.htm?path=immune-globulin-intravenous-subcutaneous-and-intramsucular-pediatric-drug-information\" class=\"drug drug_pediatric\">immune globulin</a> preparation are administered at the same visit (eg, hepatitis B vaccine and <a href=\"topic.htm?path=hepatitis-b-immune-globulin-pediatric-drug-information\" class=\"drug drug_pediatric\">hepatitis B immune globulin</a>; tetanus-containing vaccine and <a href=\"topic.htm?path=tetanus-immune-globulin-human-pediatric-drug-information\" class=\"drug drug_pediatric\">tetanus immune globulin</a>), different limbs should be used for each injection [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>].</p><p class=\"headingAnchor\" id=\"H991676486\"><span class=\"h3\">Order of administration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When multiple vaccines are required at one visit, administering the least painful vaccines first may lessen immunization-related pain and distress [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,22,44,45\" class=\"abstract_t\">20,22,44,45</a>].</p><p>For infants who require <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a>, we suggest administering rotavirus vaccine before injectable vaccines. The oral rotavirus vaccine is flavored with sucrose, which may reduce the pain associated with subsequent injections [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,46\" class=\"abstract_t\">20,46</a>]. (See <a href=\"#H397633702\" class=\"local\">'Reducing injection pain'</a> below.)</p><p>We also suggest administering other injectable vaccines before MMR and PCV13. Administration of MMR and PCV13 is perceived to be more painful than administration of other injectable vaccines [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,22,44,45\" class=\"abstract_t\">20,22,44,45</a>]. Information about the relative painfulness of other vaccines is lacking.</p><p>For infants &lt;12 months of age, if possible, we suggest administration of two injections simultaneously (by two health care providers at two different sites) rather than one after the other. Simultaneous injection may reduce injection pain for infants but does not appear to reduce distress for older children [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/22,47\" class=\"abstract_t\">22,47</a>].</p><p class=\"headingAnchor\" id=\"H397633702\"><span class=\"h2\">Reducing injection pain</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pain associated with vaccine injections, particularly when multiple injections are required, is a source of anxiety for patients and caregivers [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/48\" class=\"abstract_t\">48</a>]. Failure to adequately address pain at the time of vaccination may lead to subsequent delay or avoidance of vaccination [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,31,49-52\" class=\"abstract_t\">20,31,49-52</a>].</p><p>Systematic reviews and randomized controlled trials support several interventions to reduce the pain associated with injection of vaccines [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/22,53-55\" class=\"abstract_t\">22,53-55</a>]. The evidence of benefit is of low or moderate quality, but the interventions are unlikely to be harmful.</p><p>Interventions with little support of benefit include warming the vaccine before administration and manual tactile stimulation (eg, <span class=\"nowrap\">pinching/pressing</span> the skin near the injection site) during injection [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/22\" class=\"abstract_t\">22</a>].</p><p>Our suggestions for reducing injection pain are generally in keeping with those of professional societies (<a href=\"image.htm?imageKey=PEDS%2F114644\" class=\"graphic graphic_table graphicRef114644 \">table 10</a>) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,20,31\" class=\"abstract_t\">14,20,31</a>]:</p><p class=\"headingAnchor\" id=\"H1273833208\"><span class=\"h3\">&lt;12 months of age</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For infants &lt;12 months of age, interventions that may be helpful in reducing injection pain include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,53,56,57\" class=\"abstract_t\">20,53,56,57</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Before injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/58\" class=\"abstract_t\">58</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For infants who require <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> &ndash; Administration of rotavirus vaccine.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For infants who do not require <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> &ndash; Administration of <a href=\"topic.htm?path=sucrose-pediatric-drug-information\" class=\"drug drug_pediatric\">sucrose</a> 2 mL of 24 percent or 50 percent strength solution one to two minutes before injection [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/56,59-62\" class=\"abstract_t\">56,59-62</a>]. Glucose 2 mL of a 30 percent strength solution can be used if sucrose is not available.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Application of topical anesthetic agent (eg, cream, gel, patch) 30 to 60 minutes before injection if resources, availability, and time permit [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/63,64\" class=\"abstract_t\">63,64</a>].</p><p/><p class=\"bulletIndent2\">The risk of methemoglobinemia with topical anesthetic agents is discussed separately. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-methemoglobinemia#H1176884\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of methemoglobinemia&quot;, section on 'Topical anesthetic agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>During injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/58,65\" class=\"abstract_t\">58,65</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>If multiple injections are required and another clinician is available, administering two injections simultaneously (at different sites) rather than one after the other [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Administration of PCV13 <strong>after</strong> other injections.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Administration of MMR (if needed for travel or outbreak) <strong>after</strong> other injections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>After injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/58,66\" class=\"abstract_t\">58,66</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Swaddling, holding, <span class=\"nowrap\">side/stomach</span> position, shushing, <span class=\"nowrap\">and/or</span> rocking [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/67\" class=\"abstract_t\">67</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Therapeutic administration of <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> or <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a>.</p><p/><p class=\"headingAnchor\" id=\"H1292549169\"><span class=\"h3\">12 months through 2 years</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For children 12 through 23 months years of age, interventions that may be helpful in reducing injection pain include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,53,57\" class=\"abstract_t\">20,53,57</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Before injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking (for children who continue to breastfeed or use a pacifier).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For children &lt;2 years &ndash; Administration of <a href=\"topic.htm?path=sucrose-pediatric-drug-information\" class=\"drug drug_pediatric\">sucrose</a> [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/68\" class=\"abstract_t\">68</a>]; the typical dose is 2 mL of 24 percent or 50 percent strength solution administered one to two minutes before injection; glucose 2 mL of a 30 percent strength solution can be used if sucrose is not available [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/62\" class=\"abstract_t\">62</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Application of topical anesthetic agent (eg, cream, gel, patch) 30 to 60 minutes before injection if resources, availability, and time permit.</p><p/><p class=\"bulletIndent2\">The risk of methemoglobinemia with topical anesthetic agents is discussed separately. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-methemoglobinemia#H1176884\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of methemoglobinemia&quot;, section on 'Topical anesthetic agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>During injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking (for children who continue to breastfeed or use a pacifier).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Distraction (eg, with a video, toy) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/54\" class=\"abstract_t\">54</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Administration of PCV13 and MMR <strong>after</strong> other injections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>After injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Feeding (at breast or with bottle) or nonnutritive sucking (for children who continue to breastfeed or use a pacifier).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Stroking, rocking, or &quot;blowing the pain away.&quot;</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Therapeutic administration of <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> or <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a>.</p><p/><p class=\"headingAnchor\" id=\"H269052016\"><span class=\"h3\">3 years and older</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For children &ge;3 years, interventions that may be helpful in reducing injection pain include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20,53,57,69\" class=\"abstract_t\">20,53,57,69</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Before injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Application of topical anesthetic agent (eg, cream, gel, patch) 30 to 60 minutes before injection if resources, availability, and time permit.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>During injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For children &lt;12 years &ndash; Video, music, verbal distraction, or breathing distraction (eg, blowing bubbles or a pinwheel, deep breathing) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/54,70\" class=\"abstract_t\">54,70</a>].</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>If PCV13 or MMR are necessary, administer <strong>after</strong> other injections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>After injection</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Therapeutic administration of <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> or <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a>.</p><p/><p class=\"headingAnchor\" id=\"H3846494390\"><span class=\"h2\">Prophylactic medications</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Whether to administer</strong> &ndash; For infants and children who are receiving routine immunizations in the United States, we suggest <strong>not</strong> administering <strong>prophylactic</strong> <span class=\"nowrap\">antipyretic/analgesic</span> agents. We suggest <strong>therapeutic</strong> <span class=\"nowrap\">antipyretic/analgesic</span> agents (eg, <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a>, <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a>) for infants and children who develop fever or painful local or systemic reaction following immunizations. (See <a href=\"#H397633702\" class=\"local\">'Reducing injection pain'</a> above.)</p><p/><p class=\"bulletIndent1\">A systematic review of randomized trials found that prophylactic <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> reduced the risk of fever &ge;38&deg;C (100.4&deg;F) 24 to 48 hours after primary immunization and booster immunization in children &le;6 years [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/71\" class=\"abstract_t\">71</a>]. However, approximately one-half of children in the placebo groups remained afebrile. In addition, prophylactic administration of acetaminophen has been associated with decreased antibody concentrations for some vaccine antigens [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/72,73\" class=\"abstract_t\">72,73</a>]. The clinical significance of this finding is uncertain, given that the antibody concentrations remained in the protective range.</p><p/><p class=\"bulletIndent1\">Our suggestion not to routinely administer prophylactic <span class=\"nowrap\">antipyretic/analgesic</span> agents at the time of or within four hours after immunization is consistent with recommendations of the ACIP [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>], the World Health Organization [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/31\" class=\"abstract_t\">31</a>], and an independent Canadian clinical practice guideline [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20\" class=\"abstract_t\">20</a>]. However, in the United Kingdom, where the <a href=\"topic.htm?path=meningococcal-group-b-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">meningococcal serogroup B vaccine</a> (MenB-4C, Bexsero) is recommended during infancy, national guidelines advise administration of oral <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> as soon as possible after MenB-4C immunization, four to six hours later, and four to six hours after that [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/74,75\" class=\"abstract_t\">74,75</a>]. (See <a href=\"topic.htm?path=meningococcal-vaccines\" class=\"medical medical_review\">&quot;Meningococcal vaccines&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Choice of agent</strong> &ndash; For infants and children whose caregivers choose to administer prophylactic <span class=\"nowrap\">antipyretics/analgesics,</span> we suggest <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> rather than <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a>. We suggest that the first dose be administered within four hours after immunization.</p><p/><p class=\"bulletIndent1\">In a systematic review of the effect of prophylactic antipyretic administration, <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> reduced the risk of fever and local and systemic reactions in children &le;6 years [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/71\" class=\"abstract_t\">71</a>]. <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">Ibuprofen</a> did not reduce the risk of fever and had inconsistent effects on the risk of local and systemic reactions. One of the included trials suggested that the acetaminophen dose given around the time of vaccination is more important than doses administered &gt;4 hours after immunization [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/76\" class=\"abstract_t\">76</a>].</p><p/><p class=\"headingAnchor\" id=\"H1050348574\"><span class=\"h1\">NONSTANDARD VACCINE ADMINISTRATION</span></p><p class=\"headingAnchor\" id=\"H1227501216\"><span class=\"h2\">Invalid doses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Invalid doses need to be repeated because they may provide inadequate protection. Indications for repeating a vaccine dose include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,37\" class=\"abstract_t\">14,37</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The full age-appropriate dose of an injectable vaccine was not administered (eg, the child moves before the injection is completed)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Administration of expired vaccine</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reconstitution with the wrong diluent</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Administration of any of the following vaccines by the subcutaneous rather than the intramuscular (IM) route: hepatitis B vaccine, human papillomavirus vaccine, or <a href=\"topic.htm?path=influenza-virus-vaccine-inactivated-pediatric-drug-information\" class=\"drug drug_pediatric\">inactivated influenza vaccine</a> that is labeled for IM administration</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intradermal administration of any vaccine except the intradermal influenza vaccine</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Administration of an <strong>injectable</strong> live virus vaccine (eg, measles, mumps, and rubella vaccine; <a href=\"topic.htm?path=varicella-virus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">varicella vaccine</a>) &lt;28 days after another <strong>injectable</strong> live virus vaccine</p><p/><p>For inactivated vaccines, the invalid dose should be repeated as soon as possible. For live vaccines, the invalid dose should be repeated &ge;28 days after the invalid dose.</p><p>Doses of vaccine that are administered &ge;5 days before the <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01&amp;token=6ueO/axldHJpCyCaCNPb7uMqEZnReO+F5bq+/YAxewNZACeP57Tnw+NHc51meqNsV41MTsQnMRg053ZFXysw5aVGxhL1u1QTvFDjcP9yC40=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">recommended minimum age or interval</a> are also invalid. Invalid doses of inactivated vaccines should be repeated when the child reaches the minimum age or the recommended minimum interval has elapsed. Invalid doses of live vaccines should be repeated &ge;28 days after the invalid dose, provided that the child has reached the recommended minimum age or the recommended minimum interval as elapsed.</p><p class=\"headingAnchor\" id=\"H2349360624\"><span class=\"h2\">Doses that can be counted as valid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonstandard vaccine administration scenarios that do <strong>not</strong> require repeating the dose include [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/38\" class=\"abstract_t\">38</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vaccine that is recommended to be given subcutaneously is administered IM</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patient sneezes after nasal spray vaccine</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infant regurgitates, spits, or vomits after oral <a href=\"topic.htm?path=rotavirus-vaccine-pediatric-drug-information\" class=\"drug drug_pediatric\">rotavirus vaccine</a> (see <a href=\"topic.htm?path=rotavirus-vaccines-for-infants#H3803151\" class=\"medical medical_review\">&quot;Rotavirus vaccines for infants&quot;, section on 'Administration'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The dose that was administered was greater than the age-appropriate dose (the <span class=\"nowrap\">parent/caregiver</span> should be notified about the error)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Doses administered &lt;5 days before the minimum recommended age or interval, unless required by local or state mandates</p><p/><p class=\"headingAnchor\" id=\"H710153603\"><span class=\"h1\">VACCINE STORAGE AND HANDLING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"https://www.cdc.gov/vaccines/hcp/admin/storage/index.html&amp;token=vbqWlkdRAOlBr78RwEqtmg8VvNYcRAUcjxzXeTfYNp4qvp7dOqug4AkW0u6OTP7ua9q5KGkextSITv+axJBL6w==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Recommendations for storage and handling of vaccines</a>, including a <a href=\"https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf&amp;token=nER25DiPLJ/U80tuolpMQId9ULoR87C+/dBrwFDVbIGupoVK7RXlev/V6ehXzfEyToAoB7NLZNYQwFYe8Ga9hJAuO1RuC+YRqSmKIGYVaNQ=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">toolkit</a>, are available from the Centers for Disease Control and Prevention.</p><p class=\"headingAnchor\" id=\"H3838700171\"><span class=\"h1\">ADVERSE EVENTS</span></p><p class=\"headingAnchor\" id=\"H3715912941\"><span class=\"h2\">Local and systemic reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mild adverse local and systemic reactions occur with approximately 50 percent of vaccinations, depending upon the vaccine [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/77\" class=\"abstract_t\">77</a>]. Localized tenderness, erythema, and swelling <span class=\"nowrap\">and/or</span> mild fever are most common [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/78\" class=\"abstract_t\">78</a>]. These reactions usually resolve in one to two days without intervention.</p><p>More serious local and systemic reactions may occur. Examples include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Shoulder injury related to vaccine administration</strong> &ndash; Clinical features of shoulder injury related to vaccine administration (SIRVA) include shoulder pain and reduced range of motion at the shoulder within a few hours of vaccination without evidence of microbial infection [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/79-83\" class=\"abstract_t\">79-83</a>]. Pain and reduced function can be prolonged. Management may include physiotherapy and intra-articular glucocorticoid injections. Proper intramuscular injection technique prevents SIRVA. (See <a href=\"#H1833949965\" class=\"local\">'Immunization technique'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Febrile seizures</strong> &ndash; The risk of febrile seizures is slightly increased following certain vaccines or combinations of vaccines. Genetic susceptibility may also play a role. (See <a href=\"topic.htm?path=clinical-features-and-evaluation-of-febrile-seizures#H340716564\" class=\"medical medical_review\">&quot;Clinical features and evaluation of febrile seizures&quot;, section on 'Immunization'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Syncope</strong> &ndash; Postvaccination syncope occurs most frequently among adolescents and young adults, and can be associated with serious injury (eg, skull fracture, cerebral hemorrhage) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/84\" class=\"abstract_t\">84</a>]. Among cases of postvaccine syncope reported to the Vaccine Adverse Events Reporting System (VAERS), 80 percent occurred within 15 minutes of vaccination.</p><p/><p class=\"bulletIndent1\">To prevent secondary injury associated with syncope, the Advisory Committee on Immunization Practices suggests observation of adolescent and young adult patients for 15 minutes after vaccination [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14\" class=\"abstract_t\">14</a>]. This suggestion is particularly important for patients with risk factors for presyncope, even though presyncope does not always progress to syncope. Risk factors for presyncope include a history of passing out or nearly passing out after an injection or venipuncture, prevaccine anxiety, receiving &ge;2 shots, and more severe postvaccination pain [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/85\" class=\"abstract_t\">85</a>]. Symptoms of presyncope include dizziness, faintness, weakness, lightheadedness, facial flushing, difficulty hearing, visual disturbance, rapid or pounding heartbeat, rapid or difficult breathing, sweating, and feeling cold and sweaty or &quot;clammy.&quot; Drinking water 10 to 60 minutes before immunization does not appear to prevent presyncope in adolescents or young adults [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/85\" class=\"abstract_t\">85</a>].</p><p/><p class=\"headingAnchor\" id=\"H2660022849\"><span class=\"h3\">Risk of recurrence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of recurrence of local and systemic reactions following revaccination is uncertain. Published observational studies typically include small numbers of patients, and patients who had severe reactions (eg, anaphylaxis) often are not reimmunized. These limitations notwithstanding, a systematic review of 29 articles published between 1982 and 2016 provides estimates of the risk of recurrence of selected adverse effects [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/86\" class=\"abstract_t\">86</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extensive limb swelling following diphtheria, tetanus, acellular pertussis (DTaP) vaccine &ndash; Pooled recurrence risk of 56 percent (95% CI 9.8-46.3) in three studies including 98 children; all recovered completely</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Seizures &ndash; No recurrence in three studies</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pain &ndash; Ranged from 9 to 36 percent following diphtheria, tetanus, and pertussis-containing vaccines, depending upon the type of vaccine (whole cell versus acellular) and the dose (eight studies)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Redness <span class=\"nowrap\">and/or</span> swelling &ge;5 cm (2 inches) &ndash; Ranged from 23 to 67 percent following DTaP, depending upon the dose (three studies)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Redness <span class=\"nowrap\">and/or</span> swelling &ge;10 cm (4 inches) &ndash; 40 percent (95% CI 12 to 74 percent) following various vaccines (one study)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypotonic hyporesponsive episodes &ndash; Pooled recurrence risk of 0 percent (95% CI 0-0.1) in nine studies</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever &ndash; Ranged from 0 to 84 percent depending upon the vaccine (10 studies)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent crying &ndash; 15 to 25 percent for DTaP (two studies)</p><p/><p class=\"headingAnchor\" id=\"H4110680295\"><span class=\"h2\">Allergic reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Allergic reactions to vaccines, including the acute management of anaphylaxis and the approach to the patient with suspected vaccine allergy, are discussed separately. (See <a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">&quot;Anaphylaxis: Emergency treatment&quot;</a> and <a href=\"topic.htm?path=allergic-reactions-to-vaccines#H30\" class=\"medical medical_review\">&quot;Allergic reactions to vaccines&quot;, section on 'Approach to the patient with suspected vaccine allergy'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Reporting adverse events</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adverse events associated with vaccines should be reported to the United States Department of Health and Human Services using <a href=\"http://vaers.hhs.gov/index&amp;token=dJuRidyjQYZxq9fkueW6qyWTvn/p9jDJLlDYcIYjX1yIn9pmTuN0f+LI7X4NwNtw&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">VAERS</a> (telephone number 1-800-822-7967).</p><p>The National Childhood Vaccine Injury Act requires health care providers in the United States to report:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adverse events listed in the <a href=\"http://vaers.hhs.gov/resources/infoproviders.html&amp;token=dJuRidyjQYZxq9fkueW6q5RXMgIB5hHyLl9ubk9P0tSwPyo0c9wq0IchpZ2xqcpr8B2onhjom8cvfpouGYvwFA==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">VAERS table of reportable events following vaccination</a></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adverse events that are listed by the vaccine manufacturer</p><p/><p>The Centers for Disease Control and Prevention also encourages health care providers to report any clinically significant adverse event that occurs after vaccination, even if it is unclear whether the vaccine caused the event [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/87\" class=\"abstract_t\">87</a>].</p><p class=\"headingAnchor\" id=\"H3968372383\"><span class=\"h1\">VACCINATION COVERAGE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>National, regional, and state vaccination coverage estimates for <a href=\"https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/data-reports/index.html&amp;token=9Az6dzCgEGGe9Exb5avjwMH7Ip8QFXHoftCupT5ITzynSwkz5w8pD8mRwnbgkpOtFyhoxxr47NAlp29yxOyKyo+9f1KdnTHHcuJTu4z6fSCvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">children 19 to 35 months</a>, <a href=\"https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/data-reports/index.html&amp;token=GhCi4kcCWrW4eVfWrl2bnuXWOsf4nHcI5qEwJDMstUNE+Pcf+b5rxhpVBMWqpRms91VYLBL8k0GWv8aUuS6bkTPBnPsaFgtqVPBkWPxNU3z8MMZmh52VHY0ZA4IFDo5U&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">children enrolled in kindergarten</a>, and <a href=\"https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/index.html&amp;token=CVhhc5+LNy3VmiRuv1YVmPXyji+Ka7bpbOkKZbj1m37lpYpvbvZuwryxorYm5u4YNjilMzZAnxE2kFUqcUEkHLD+DVk3hEUFM4fqmybDcuc=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">teenagers</a> are available from the <a href=\"https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/index.html&amp;token=A9Ymtmr7XzJM4wLdcspeOrmEJRuLiHApHHlKMUumec/StO8GWrUKzGQIZsTHlSLPTrZYs5U+Knqjxq2hFNwWsf2QOIMAv0m8oMOPLSkWvkI=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention</a>. National age-appropriate vaccine coverage generally is &gt;90 percent for most routinely recommended vaccines in preschool- and kindergarten-aged children. Age-appropriate vaccine coverage is lower among adolescents, with rates of approximately 88 percent for &ge;1 dose of Tdap, 82 percent for &ge;1 dose of meningococcal conjugate vaccine, 65 percent for &ge;1 dose of human papillomavirus (HPV) vaccine among female adolescents and 56 percent for &ge;1 dose of HPV vaccine among male adolescents [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/88\" class=\"abstract_t\">88</a>].</p><p>Provider-focused strategies to increase vaccination coverage include: use of combination vaccines [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/7,9\" class=\"abstract_t\">7,9</a>]; reminder or recall systems, including text messaging [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/89-91\" class=\"abstract_t\">89-91</a>]; electronic medical record alerts that the patient is due for specific vaccines; and use of standing orders for immunization to avoid missed opportunities for immunization [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/14,18\" class=\"abstract_t\">14,18</a>]. <a href=\"http://www.immunize.org/standing-orders/&amp;token=Xhpv4YrGbNrLf4iLM2FgO+GcGfgxhKBFpfSbo5zhlzysHkCqKhce14imArEAiWNurwC1JCwUsNIWoeWxLU0oqw==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">The Immunization Action Coalition</a> provides resources for implementing standing orders for immunization. A systematic review of 55 randomized and observational studies concluded that reminder and recall messages probably are effective in increasing immunization rates in primary care (by an average of 8 percent) [<a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/91\" class=\"abstract_t\">91</a>].</p><p class=\"headingAnchor\" id=\"H1319761862\"><span class=\"h1\">RESOURCES</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The Centers for Disease Control and Prevention provides a number of vaccine-related resources, including:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"https://www.cdc.gov/vaccines/hcp/vis/current-vis.html&amp;token=R4Uiw8/bmPVaqNHRDqpXLAH/K5ePuSCWLS93Qnaa3r/5qdQw/NYQGK1y+HqFU7TkRZLnBxvqrSwSUrCQcXZVSA==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Vaccine information statements</a></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A list of <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html#t-01&amp;token=6ueO/axldHJpCyCaCNPb7mHVrSmDPVTmUZqlyjUwPWA2E+zSFV1qRAZwVZzcsMt7hVW5Sj+7i39F1S9Glgtnx1GqqYVj+NHr5juvqXVbacY=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">contraindications and precautions</a> to commonly used vaccines</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"http://www2a.cdc.gov/nip/kidstuff/newscheduler_le/&amp;token=7LagjMXRT8rv1l0AMXLvnOT3uh2s8ajsjyoPjrX7EFmF58YfSf8HFVxQGVvIQ5XGiJpfwCyXABD0qYouQH9mOw==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Instant Childhood Immunization Schedule</a>, a personal, customized immunization schedule based upon the child's birth date</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"https://www.vacscheduler.org/index.html&amp;token=SuIB1u+8CxNihPQlX6Mo9jbYiokzYGStxu8qoOAa2ih6a0YmE+yjCFg7tj2Jzjon&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Catch-up immunization scheduler for children &le;6 years</a></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Information regarding <a href=\"https://www.cdc.gov/vaccines/hcp/admin/admin-protocols.html&amp;token=R4Uiw8/bmPVaqNHRDqpXLAH/K5ePuSCWLS93Qnaa3r+ukUj05ViRKBL5wyhaXTZ1kK5Dour98IypaLWsUJ21Bw==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">vaccine administration</a></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"https://www.cdc.gov/vaccines/pubs/pinkbook/index.html&amp;token=R4Uiw8/bmPVaqNHRDqpXLPYxS7yIpma2orsm+TVpww8w2d/mMC8G2EDPT1a9sS+QisajaHJZWQcYGNLisQTMZQ==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Epidemiology and Prevention of Vaccine-Preventable Diseases</a> (The Pink Book)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>An updated list of <a href=\"https://www.cdc.gov/vaccines/hcp/clinical-resources/shortages.html&amp;token=E/bWRQLLxxHwfbAUtQyg03TroTU9sHx/gEUJ/cRdpJt8w8Y2eALHBOQ8rIEH/YPi6eHQHipTgMLTbxoypLzCbEZ3vPXyls9eLzYKunXSeLQ=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">vaccine shortages and delays</a></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>State specific <a href=\"https://www.cdc.gov/phlp/publications/topic/vaccinations.html&amp;token=DLsj7d2M4JeDWUd5lrQ+XYamzh9j51lDuN5f9HD5edOtHt65V0Ut2Ip0/i6c0x0lonhmhyBK99ZO8CF3MirDzg==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">vaccine requirements for daycare and school entry</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The Immunization Action Coalition provides numerous resources for <a href=\"http://www.immunize.org/&amp;token=Xhpv4YrGbNrLf4iLM2FgO9OU7+srHa6FtzbbO0PYVVSvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">health professionals</a> and <a href=\"http://www.vaccineinformation.org/&amp;token=6g5UpsuthFnSGzoQK/MSsyBJEbPxIwf2RPd3HRtpRJevbLZKl8VdTru3HotNat1P&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">the public</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The Institute for Safe Medication Practices provides <a href=\"http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=104&amp;token=aQ9CdAmYWuaA87VJnG/Q+jUmftkhcECLDkZ/qZiwqrSeIgSxRzbgVnjed3OA2M76csaA+6wvxNCYfy+t45yURn4mCT4kRWqcW9EE11byNe4=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">recommendations for practitioners to prevent vaccine errors</a></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.adolescentvaccination.org/&amp;token=pA/JFTzFzVWnmq81WzE5RXOXhHozE1T7QbNnGTWYSPUaOZ8RabwigSyrvfEGhYuv&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">National Foundation for Infectious Diseases</a> and <a href=\"http://www.aafpfoundation.org/foundation/our-work/grants-awards/all/HighlightonVaccinations4Teens/HOV4TResourceLibrary.html&amp;token=rtpWUiLhwve5xQz7LUBV3LbL95y5suCDJf9do1Bpd2Qb/XcyAIZGyIyfUBxG7RN1GPoBgGXsL6GRtFVHltz3yqAk8/PhQX1Au9PzSmSFBE6efG3aNA7VJ44QS/3Qgvkc67PptbIiEG0W5PMdiGJdww==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">American Academy of Family Physicians</a> provide resources related to immunizations for adolescents</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The US Food and Drug Administration maintains a list of <a href=\"https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm093833.htm&amp;token=Lii8N8sRO+XG1OzCp+MBbDxCZyNAO1+lfJeo9F4z36p2Xq/gnatgEch3CQO1CZL2IbWQo2tdOXBnH+ncdoHqrQsIj0QTlhZqXrY6CZ+Zw74=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">vaccines licensed in the United States</a></p><p/><p class=\"headingAnchor\" id=\"H3534753784\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-immunizations-in-children-and-adolescents\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Immunizations in children and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword[s] of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=vaccines-for-babies-and-children-age-0-to-6-years-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Vaccines for babies and children age 0 to 6 years (The Basics)&quot;</a> and <a href=\"topic.htm?path=vaccines-for-children-age-7-to-18-years-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Vaccines for children age 7 to 18 years (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=why-does-my-child-need-vaccines-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Why does my child need vaccines? (Beyond the Basics)&quot;</a> and <a href=\"topic.htm?path=vaccines-for-infants-and-children-age-0-to-6-years-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)&quot;</a> and <a href=\"topic.htm?path=vaccines-for-children-age-7-to-18-years-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Vaccines for children age 7 to 18 years (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H2115055251\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Universally recommended vaccines for children and adolescents in the United States include: hepatitis B; rotavirus; diphtheria, tetanus, pertussis; <em>Haemophilus influenzae</em> type b; pneumococcal conjugate; inactivated polio; seasonal influenza; measles, mumps, rubella; varicella-zoster virus; hepatitis A; meningococcus; and human papillomavirus (<a href=\"image.htm?imageKey=PEDS%2F82617%7EPEDS%2F58209\" class=\"graphic graphic_figure graphicRef82617 graphicRef58209 \">figure 2A-B</a>). Immunization schedules for other countries are available through the <a href=\"http://apps.who.int/immunization_monitoring/globalsummary&amp;token=OwnNIPPeGk/rbsSIEMq0IgOjNOv7VUbbhIG6Z6gMcV0Dql41+3EEqSmN6lmXxVXDaQVNaZmvR6hPn+vQ/s4dzQ==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">World Health Organization</a>. (See <a href=\"#H645243885\" class=\"local\">'Routine schedule'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Children who are behind on vaccines should be caught up using the minimum intervals between doses (<a href=\"image.htm?imageKey=PEDS%2F58271%7EPEDS%2F72079\" class=\"graphic graphic_table graphicRef58271 graphicRef72079 \">table 7A-B</a>). It is not necessary to restart the series &ndash; even when the interval between doses is prolonged. (See <a href=\"#H3005310320\" class=\"local\">'Catch-up schedule'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The Advisory Committee on Immunization Practices provides best practice recommendations for vaccine administration, including <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html&amp;token=M248bh7IdGqnqxfWhes+J2OLp4ehXZM6B5KjsvWXKbGmXZNygyKmlRe/g1IjGlLmpxdjSJ9Kqpgdkm31MvyqvSn0WM1CtcQfLymHDU/edSY=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">minimum ages and intervals between vaccine doses</a>, as well as the recommended dose, route, and site of administration for individual vaccines (<a href=\"image.htm?imageKey=PEDS%2F114641\" class=\"graphic graphic_table graphicRef114641 \">table 9</a>). (See <a href=\"#H3599497874\" class=\"local\">'Vaccine administration'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preadministration counseling includes provision of <a href=\"https://www.cdc.gov/vaccines/hcp/vis/current-vis.html&amp;token=R4Uiw8/bmPVaqNHRDqpXLAH/K5ePuSCWLS93Qnaa3r/5qdQw/NYQGK1y+HqFU7TkRZLnBxvqrSwSUrCQcXZVSA==&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">vaccine information statements</a>, assessing for <a href=\"https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html&amp;token=sNGgq5VkfSaPHLmX/yNS2NujPwEAot7zqSbWqNH0vSPGn6dBXKG78J8uYDX6HXTCxeMN8cKDGumsphZDQg5hrjwLwn5jOqpCiNWWeYI75AA=&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">contraindications and precautions</a>, and educating <span class=\"nowrap\">parents/caregivers</span> and patients about management of vaccine-related pain. (See <a href=\"#H1184246441\" class=\"local\">'Preadministration counseling'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most of the routinely recommended childhood vaccines are injected intramuscularly or subcutaneously (<a href=\"image.htm?imageKey=PEDS%2F114641\" class=\"graphic graphic_table graphicRef114641 \">table 9</a>). The preferred position of the child, site of injection, and strategies to reduce injection pain vary with age (<a href=\"image.htm?imageKey=PEDS%2F114644\" class=\"graphic graphic_table graphicRef114644 \">table 10</a>). (See <a href=\"#H5\" class=\"local\">'Injectable vaccines'</a> above and <a href=\"#H397633702\" class=\"local\">'Reducing injection pain'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adverse events associated with vaccines should be reported to the United States Department of Health and Human Services using the <a href=\"http://vaers.hhs.gov/index&amp;token=dJuRidyjQYZxq9fkueW6qyWTvn/p9jDJLlDYcIYjX1yIn9pmTuN0f+LI7X4NwNtw&amp;TOPIC_ID=2876\" target=\"_blank\" class=\"external\">Vaccine Adverse Events Reporting System</a> (telephone number 1-800-822-7967). (See <a href=\"#H8\" class=\"local\">'Reporting adverse events'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/1\" class=\"nounderline abstract_t\">Maciosek MV, LaFrance AB, Dehmer SP, et al. Updated Priorities Among Effective Clinical Preventive Services. Ann Fam Med 2017; 15:14.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/2\" class=\"nounderline abstract_t\">Whitney CG, Zhou F, Singleton J, et al. Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 2014; 63:352.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/3\" class=\"nounderline abstract_t\">Meissner HC. Why is herd immunity so important. AAP News 2015; 36:14.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/4\" class=\"nounderline abstract_t\">Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis 2012; 25:243.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/5\" class=\"nounderline abstract_t\">Robinson CL, Romero JR, Kempe A, et al. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2018. MMWR Morb Mortal Wkly Rep 2018; 67:156.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/6\" class=\"nounderline abstract_t\">Zangwill KM, Eriksen E, Lee M, et al. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Pediatrics 2008; 122:e1179.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/7\" class=\"nounderline abstract_t\">Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007; 26:496.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/8\" class=\"nounderline abstract_t\">Guerra FA, Blatter MM, Greenberg DP, et al. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Pediatrics 2009; 123:301.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/9\" class=\"nounderline abstract_t\">Kurosky SK, Davis KL, Galindo CM. Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States. Pediatr Infect Dis J 2017; 36:e189.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/10\" class=\"nounderline abstract_t\">Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season. MMWR Recomm Rep 2017; 66:1.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/11\" class=\"nounderline abstract_t\">Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/12\" class=\"nounderline abstract_t\">Society for Adolescent Health and Medicine. Establishing an Immunization Platform for 16-Year-Olds in the United States. J Adolesc Health 2017; 60:475.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/13\" class=\"nounderline abstract_t\">Bernstein HH, Bocchini JA Jr, COMMITTEE ON INFECTIOUS DISEASES. Practical Approaches to Optimize Adolescent Immunization. Pediatrics 2017; 139.</a></li><li class=\"breakAll\">Kroger AT, Duchin J, V&aacute;zquez M. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html (Accessed on April 27, 2017).</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/15\" class=\"nounderline abstract_t\">Bernstein HH, Bocchini JA Jr, COMMITTEE ON INFECTIOUS DISEASES. The Need to Optimize Adolescent Immunization. Pediatrics 2017; 139.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/16\" class=\"nounderline abstract_t\">Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/17\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1705.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/18\" class=\"nounderline abstract_t\">Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:817.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/19\" class=\"nounderline abstract_t\">Evans DI, Shaw A. Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs. BMJ 1990; 300:1694.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/20\" class=\"nounderline abstract_t\">Taddio A, McMurtry CM, Shah V, et al. Reducing pain during vaccine injections: clinical practice guideline. CMAJ 2015; 187:975.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Vaccine administration. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.26.</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/22\" class=\"nounderline abstract_t\">Taddio A, Shah V, McMurtry CM, et al. Procedural and Physical Interventions for Vaccine Injections: Systematic Review of Randomized Controlled Trials and Quasi-Randomized Controlled Trials. Clin J Pain 2015; 31:S20.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/23\" class=\"nounderline abstract_t\">Shaw FE Jr, Guess HA, Roets JM, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7:425.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/24\" class=\"nounderline abstract_t\">de Lalla F, Rinaldi E, Santoro D, Pravettoni G. Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study. Eur J Epidemiol 1988; 4:256.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/25\" class=\"nounderline abstract_t\">Diggle L, Deeks JJ, Pollard AJ. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ 2006; 333:571.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/26\" class=\"nounderline abstract_t\">Poland GA, Borrud A, Jacobson RM, et al. Determination of deltoid fat pad thickness. Implications for needle length in adult immunization. JAMA 1997; 277:1709.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/27\" class=\"nounderline abstract_t\">Groswasser J, Kahn A, Bouche B, et al. Needle length and injection technique for efficient intramuscular vaccine delivery in infants and children evaluated through an ultrasonographic determination of subcutaneous and muscle layer thickness. Pediatrics 1997; 100:400.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/28\" class=\"nounderline abstract_t\">Jackson LA, Starkovich P, Dunstan M, et al. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination. Pediatrics 2008; 121:e646.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/29\" class=\"nounderline abstract_t\">Beirne PV, Hennessy S, Cadogan SL, et al. Needle size for vaccination procedures in children and adolescents. Cochrane Database Syst Rev 2015; :CD010720.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/30\" class=\"nounderline abstract_t\">Lippert WC, Wall EJ. Optimal intramuscular needle-penetration depth. Pediatrics 2008; 122:e556.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/31\" class=\"nounderline abstract_t\">WHO. Reducing pain at the time of vaccination: WHO position paper, September 2015-Recommendations. Vaccine 2016; 34:3629.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/32\" class=\"nounderline abstract_t\">Taddio A, Ilersich AL, Ipp M, et al. Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials. Clin Ther 2009; 31 Suppl 2:S48.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/33\" class=\"nounderline abstract_t\">Ipp M, Taddio A, Sam J, et al. Vaccine-related pain: randomised controlled trial of two injection techniques. Arch Dis Child 2007; 92:1105.</a></li><li class=\"breakAll\">Administration of vaccines. In The Australian Immunisation Handbook, 10th ed. Available at:http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home (Accessed on August 16, 2017)./u003c/li/u003e/u003cli/u003e/u003ca href/u003d\"/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/35\" class=\"nounderline abstract_t\">Cook IF. An evidence based protocol for the prevention of upper arm injury related to vaccine administration (UAIRVA). Hum Vaccin 2011; 7:845.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/36\" class=\"nounderline abstract_t\">Wadman M. Vaccines on trial. Science 2017; 356:370.</a></li><li class=\"breakAll\">Immunization Action Coalition. Ask the experts. Administering vaccines. Available at:http://www.immunize.org/askexperts/administering-vaccines.asp (Accessed on August 21, 2017)./u003c/li/u003e/u003cli/u003e/u003ca href/u003d\"/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/38\" class=\"nounderline abstract_t\">Guerra FA, Gress J, Werzberger A, et al. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Pediatr Infect Dis J 2006; 25:912.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/39\" class=\"nounderline abstract_t\">Nolan T, Bernstein H, Blatter MM, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Pediatrics 2006; 118:e602.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/40\" class=\"nounderline abstract_t\">Dagan R, Amir J, Livni G, et al. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial. Pediatr Infect Dis J 2007; 26:787.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/41\" class=\"nounderline abstract_t\">Trofa AF, Klein NP, Paul IM, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age. Pediatr Infect Dis J 2011; 30:e164.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/42\" class=\"nounderline abstract_t\">Rinderknecht S, Michaels MG, Blatter M, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age. Pediatr Infect Dis J 2011; 30:e179.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Scheduling immunizations. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.31.</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/44\" class=\"nounderline abstract_t\">Ipp M, Parkin PC, Lear N, et al. Order of vaccine injection and infant pain response. Arch Pediatr Adolesc Med 2009; 163:469.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/45\" class=\"nounderline abstract_t\">Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. CMAJ 2010; 182:E843.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/46\" class=\"nounderline abstract_t\">Taddio A, Flanders D, Weinberg E, et al. A randomized trial of rotavirus vaccine versus sucrose solution for vaccine injection pain. Vaccine 2015; 33:2939.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/47\" class=\"nounderline abstract_t\">Horn MI, McCarthy AM. Children's responses to sequential versus simultaneous immunization injections. J Pediatr Health Care 1999; 13:18.</a></li><li class=\"breakAll\">Report to SAGE on reducing pain and distress at the time of vaccination. March 2015. Available at: http://www.who.int/immunization/sage/meetings/2015/april/1_SAGE_latest_pain_guidelines_March_24_Final.pdf?ua=1 (Accessed on August 15, 2017).</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/49\" class=\"nounderline abstract_t\">Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations. Wkly Epidemiol Rec 2015; 90:261.</a></li><li class=\"breakAll\">Report of the SAGE Working Group on vaccine hesitancy. October 2014. Available at: http://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf (Accessed on August 15, 2017).</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/51\" class=\"nounderline abstract_t\">Taddio A, Chambers CT, Halperin SA, et al. Inadequate pain management during routine childhood immunizations: the nerve of it. Clin Ther 2009; 31 Suppl 2:S152.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/52\" class=\"nounderline abstract_t\">Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 2012; 30:4807.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/53\" class=\"nounderline abstract_t\">Shah V, Taddio A, McMurtry CM, et al. Pharmacological and Combined Interventions to Reduce Vaccine Injection Pain in Children and Adults: Systematic Review and Meta-Analysis. Clin J Pain 2015; 31:S38.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/54\" class=\"nounderline abstract_t\">Birnie KA, Chambers CT, Taddio A, et al. Psychological Interventions for Vaccine Injections in Children and Adolescents: Systematic Review of Randomized and Quasi-Randomized Controlled Trials. Clin J Pain 2015; 31:S72.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/55\" class=\"nounderline abstract_t\">Pillai Riddell R, Taddio A, McMurtry CM, et al. Psychological Interventions for Vaccine Injections in Young Children 0 to 3 Years: Systematic Review of Randomized Controlled Trials and Quasi-Randomized Controlled Trials. Clin J Pain 2015; 31:S64.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/56\" class=\"nounderline abstract_t\">Harrison D, Larocque C, Bueno M, et al. Sweet Solutions to Reduce Procedural Pain in Neonates: A Meta-analysis. Pediatrics 2017; 139.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Managing injection pain. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.31.</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/58\" class=\"nounderline abstract_t\">Harrison D, Reszel J, Bueno M, et al. Breastfeeding for procedural pain in infants beyond the neonatal period. Cochrane Database Syst Rev 2016; 10:CD011248.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/59\" class=\"nounderline abstract_t\">Harrison D, Stevens B, Bueno M, et al. Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review. Arch Dis Child 2010; 95:406.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/60\" class=\"nounderline abstract_t\">Stevens B, Yamada J, Ohlsson A, et al. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev 2016; 7:CD001069.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/61\" class=\"nounderline abstract_t\">Kassab M, Foster JP, Foureur M, Fowler C. Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age. Cochrane Database Syst Rev 2012; 12:CD008411.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/62\" class=\"nounderline abstract_t\">Thyr M, Sundholm A, Teeland L, Rahm VA. Oral glucose as an analgesic to reduce infant distress following immunization at the age of 3, 5 and 12 months. Acta Paediatr 2007; 96:233.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/63\" class=\"nounderline abstract_t\">Taddio A, Riddell RP, Ipp M, et al. Relative effectiveness of additive pain interventions during vaccination in infants. CMAJ 2017; 189:E227.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/64\" class=\"nounderline abstract_t\">Gupta NK, Upadhyay A, Agarwal A, et al. Randomized controlled trial of topical EMLA and breastfeeding for reducing pain during wDPT vaccination. Eur J Pediatr 2013; 172:1527.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/65\" class=\"nounderline abstract_t\">Shah PS, Aliwalas L, Shah V. Breastfeeding or breastmilk to alleviate procedural pain in neonates: a systematic review. Breastfeed Med 2007; 2:74.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/66\" class=\"nounderline abstract_t\">Pillai Riddell RR, Racine NM, Gennis HG, et al. Non-pharmacological management of infant and young child procedural pain. Cochrane Database Syst Rev 2015; :CD006275.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/67\" class=\"nounderline abstract_t\">Harrington JW, Logan S, Harwell C, et al. Effective analgesia using physical interventions for infant immunizations. Pediatrics 2012; 129:815.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/68\" class=\"nounderline abstract_t\">Yilmaz G, Caylan N, Oguz M, Karacan CD. Oral sucrose administration to reduce pain response during immunization in 16-19-month infants: a randomized, placebo-controlled trial. Eur J Pediatr 2014; 173:1527.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/69\" class=\"nounderline abstract_t\">Chambers CT, Taddio A, Uman LS, et al. Psychological interventions for reducing pain and distress during routine childhood immunizations: a systematic review. Clin Ther 2009; 31 Suppl 2:S77.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/70\" class=\"nounderline abstract_t\">Berberich FR, Landman Z. Reducing immunization discomfort in 4- to 6-year-old children: a randomized clinical trial. Pediatrics 2009; 124:e203.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/71\" class=\"nounderline abstract_t\">Das RR, Panigrahi I, Naik SS. The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PLoS One 2014; 9:e106629.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/72\" class=\"nounderline abstract_t\">Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009; 374:1339.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/73\" class=\"nounderline abstract_t\">Doed&eacute;e AM, Boland GJ, Pennings JL, et al. Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials. PLoS One 2014; 9:e98175.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/74\" class=\"nounderline abstract_t\">Braccio S, Saliba V, Ramsay M, Ladhani SN. Question 1: Does prophylactic paracetamol prevent fever after vaccination in infants? Arch Dis Child 2015; 100:1178.</a></li><li class=\"breakAll\">Meningococcal B (MenB) vaccination programme. Available at: https://www.gov.uk/government/collections/meningococcal-b-menb-vaccination-programme (Accessed on July 31, 2017).</li><li class=\"breakAll\">Study assessing the effect of medications to prevent fever on Prevenar 13. Available at: https://clinicaltrials.gov/ct2/show/NCT01392378 (Accessed on July 31, 2017).</li><li class=\"breakAll\">Centers for Disease Control and Prevention. Possible side-effects from vaccines. Available at: https://www.cdc.gov/vaccines/vac-gen/side-effects.htm (Accessed on August 21, 2017).</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/78\" class=\"nounderline abstract_t\">Babl FE, Lewena S, Brown L. Vaccination-related adverse events. Pediatr Emerg Care 2006; 22:514.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/79\" class=\"nounderline abstract_t\">Cross GB, Moghaddas J, Buttery J, et al. Don't aim too high: Avoiding shoulder injury related to vaccine administration. Aust Fam Physician 2016; 45:303.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/80\" class=\"nounderline abstract_t\">Salmon JH, Geoffroy M, Eschard JP, Ohl X. Bone erosion and subacromial bursitis caused by diphtheria-tetanus-poliomyelitis vaccine. Vaccine 2015; 33:6152.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/81\" class=\"nounderline abstract_t\">Cook IF. Subdeltoid/subacromial bursitis associated with influenza vaccination. Hum Vaccin Immunother 2014; 10:605.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/82\" class=\"nounderline abstract_t\">Barnes MG, Ledford C, Hogan K. A &quot;needling&quot; problem: shoulder injury related to vaccine administration. J Am Board Fam Med 2012; 25:919.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/83\" class=\"nounderline abstract_t\">Atanasoff S, Ryan T, Lightfoot R, Johann-Liang R. Shoulder injury related to vaccine administration (SIRVA). Vaccine 2010; 28:8049.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/84\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Syncope after vaccination--United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008; 57:457.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/85\" class=\"nounderline abstract_t\">Kemper AR, Barnett ED, Walter EB, et al. Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial. Pediatrics 2017; 140.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/86\" class=\"nounderline abstract_t\">Zafack JG, De Serres G, Kiely M, et al. Risk of Recurrence of Adverse Events Following Immunization: A Systematic Review. Pediatrics 2017; 140.</a></li><li class=\"breakAll\">Vaccine Adverse Event Reporting System. Information for healthcare providers. Available at: https://vaers.hhs.gov/resources/infoproviders.html (Accessed on August 08, 2017).</li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/88\" class=\"nounderline abstract_t\">Walker TY, Elam-Evans LD, Singleton JA, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:874.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/89\" class=\"nounderline abstract_t\">Stockwell MS, Kharbanda EO, Martinez RA, et al. Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. Am J Public Health 2012; 102:e15.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/90\" class=\"nounderline abstract_t\">Suh CA, Saville A, Daley MF, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012; 129:e1437.</a></li><li><a href=\"https://www.uptodate.com/contents/standard-immunizations-for-children-and-adolescents-overview/abstract/91\" class=\"nounderline abstract_t\">Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, et al. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev 2018; 1:CD003941.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2876 Version 81.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2115055251\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H81498659\" id=\"outline-link-H81498659\">BENEFITS OF VACCINES</a></li><li><a href=\"#H645243885\" id=\"outline-link-H645243885\">ROUTINE SCHEDULE</a><ul><li><a href=\"#H3167808447\" id=\"outline-link-H3167808447\">Infants and children</a></li><li><a href=\"#H4095257626\" id=\"outline-link-H4095257626\">Adolescents</a></li></ul></li><li><a href=\"#H3005310320\" id=\"outline-link-H3005310320\">CATCH-UP SCHEDULE</a></li><li><a href=\"#H359865919\" id=\"outline-link-H359865919\">VACCINE HESITANCY OR REFUSAL</a></li><li><a href=\"#H442888927\" id=\"outline-link-H442888927\">OTHER SPECIAL CIRCUMSTANCES</a></li><li><a href=\"#H3599497874\" id=\"outline-link-H3599497874\">VACCINE ADMINISTRATION</a><ul><li><a href=\"#H1184246441\" id=\"outline-link-H1184246441\">Preadministration counseling</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Injectable vaccines</a><ul><li><a href=\"#H3928209354\" id=\"outline-link-H3928209354\">- Patient position</a></li><li><a href=\"#H1833949965\" id=\"outline-link-H1833949965\">- Immunization technique</a></li></ul></li><li><a href=\"#H416059916\" id=\"outline-link-H416059916\">Oral vaccines</a></li><li><a href=\"#H680783462\" id=\"outline-link-H680783462\">Intranasal vaccines</a></li><li><a href=\"#H2561276728\" id=\"outline-link-H2561276728\">Administration of multiple vaccines at one visit</a><ul><li><a href=\"#H2672370466\" id=\"outline-link-H2672370466\">- Timing and spacing</a></li><li><a href=\"#H2827536485\" id=\"outline-link-H2827536485\">- Site of injections</a></li><li><a href=\"#H991676486\" id=\"outline-link-H991676486\">- Order of administration</a></li></ul></li><li><a href=\"#H397633702\" id=\"outline-link-H397633702\">Reducing injection pain</a><ul><li><a href=\"#H1273833208\" id=\"outline-link-H1273833208\">- &lt;12 months of age</a></li><li><a href=\"#H1292549169\" id=\"outline-link-H1292549169\">- 12 months through 2 years</a></li><li><a href=\"#H269052016\" id=\"outline-link-H269052016\">- 3 years and older</a></li></ul></li><li><a href=\"#H3846494390\" id=\"outline-link-H3846494390\">Prophylactic medications</a></li></ul></li><li><a href=\"#H1050348574\" id=\"outline-link-H1050348574\">NONSTANDARD VACCINE ADMINISTRATION</a><ul><li><a href=\"#H1227501216\" id=\"outline-link-H1227501216\">Invalid doses</a></li><li><a href=\"#H2349360624\" id=\"outline-link-H2349360624\">Doses that can be counted as valid</a></li></ul></li><li><a href=\"#H710153603\" id=\"outline-link-H710153603\">VACCINE STORAGE AND HANDLING</a></li><li><a href=\"#H3838700171\" id=\"outline-link-H3838700171\">ADVERSE EVENTS</a><ul><li><a href=\"#H3715912941\" id=\"outline-link-H3715912941\">Local and systemic reactions</a><ul><li><a href=\"#H2660022849\" id=\"outline-link-H2660022849\">- Risk of recurrence</a></li></ul></li><li><a href=\"#H4110680295\" id=\"outline-link-H4110680295\">Allergic reactions</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Reporting adverse events</a></li></ul></li><li><a href=\"#H3968372383\" id=\"outline-link-H3968372383\">VACCINATION COVERAGE</a></li><li><a href=\"#H1319761862\" id=\"outline-link-H1319761862\">RESOURCES</a></li><li><a href=\"#H3534753784\" id=\"outline-link-H3534753784\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H63\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H2115055251\" id=\"outline-link-H2115055251\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/2876|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/58899\" class=\"graphic graphic_figure\">- Vaccine effectiveness</a></li><li><a href=\"image.htm?imageKey=PEDS/82617\" class=\"graphic graphic_figure\">- Childhood immunization schedule 0 through 6 years</a></li><li><a href=\"image.htm?imageKey=PEDS/58209\" class=\"graphic graphic_figure\">- Childhood immunization schedule 7 through 18 years</a></li><li><a href=\"image.htm?imageKey=PEDS/114649\" class=\"graphic graphic_figure\">- Holding children for vaccines</a></li><li><a href=\"image.htm?imageKey=PEDS/114647\" class=\"graphic graphic_figure\">- Anterolateral thigh injection site</a></li><li><a href=\"image.htm?imageKey=PEDS/114650\" class=\"graphic graphic_figure\">- Ventrogluteal injection site</a></li><li><a href=\"image.htm?imageKey=PEDS/114648\" class=\"graphic graphic_figure\">- Deltoid injection site</a></li></ul></li><li><div id=\"PEDS/2876|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/76345\" class=\"graphic graphic_table\">- HBV immunoprophylaxis for infants with BW 2 kg or more</a></li><li><a href=\"image.htm?imageKey=PEDS/55139\" class=\"graphic graphic_table\">- HBV immunoprophylaxis for infants with BW less than 2 kg</a></li><li><a href=\"image.htm?imageKey=PEDS/70478\" class=\"graphic graphic_table\">- Rotavirus vaccines summary</a></li><li><a href=\"image.htm?imageKey=ID/77170\" class=\"graphic graphic_table\">- Hib schedule US</a></li><li><a href=\"image.htm?imageKey=ID/78224\" class=\"graphic graphic_table\">- IPV formulations</a></li><li><a href=\"image.htm?imageKey=PEDS/72029\" class=\"graphic graphic_table\">- Groups at high risk for influenza complications</a></li><li><a href=\"image.htm?imageKey=ID/79474\" class=\"graphic graphic_table\">- Influenza vaccines summary</a></li><li><a href=\"image.htm?imageKey=PEDS/58271\" class=\"graphic graphic_table\">- Catch-up immunization schedule age 4 months through 6 years</a></li><li><a href=\"image.htm?imageKey=PEDS/72079\" class=\"graphic graphic_table\">- Catch-up immunization schedule for children 7 through 18 years</a></li><li><a href=\"image.htm?imageKey=PEDS/72640\" class=\"graphic graphic_table\">- MMR and VZV in immune globulin or blood product recipients</a></li><li><a href=\"image.htm?imageKey=PEDS/114641\" class=\"graphic graphic_table\">- Summary vaccine administration for children</a></li><li><a href=\"image.htm?imageKey=PEDS/114644\" class=\"graphic graphic_table\">- Vaccine injection procedure children and adolescents</a></li><li><a href=\"image.htm?imageKey=PEDS/60863\" class=\"graphic graphic_table\">- Needle length IM shots</a></li><li><a href=\"image.htm?imageKey=ID/112956\" class=\"graphic graphic_table\">- Live vaccines</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=allergic-reactions-to-vaccines\" class=\"medical medical_review\">Allergic reactions to vaccines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anaphylaxis-emergency-treatment\" class=\"medical medical_review\">Anaphylaxis: Emergency treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-evaluation-of-febrile-seizures\" class=\"medical medical_review\">Clinical features and evaluation of febrile seizures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-methemoglobinemia\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of methemoglobinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-children-7-through-18-years-of-age\" class=\"medical medical_review\">Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diphtheria-tetanus-and-pertussis-immunization-in-infants-and-children-0-through-6-years-of-age\" class=\"medical medical_review\">Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-a-virus-infection-treatment-and-prevention\" class=\"medical medical_review\">Hepatitis A virus infection: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">Hepatitis B virus immunization in infants, children, and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=human-papillomavirus-vaccination\" class=\"medical medical_review\">Human papillomavirus vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-during-pregnancy\" class=\"medical medical_review\">Immunizations during pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-for-travel\" class=\"medical medical_review\">Immunizations for travel</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-in-hiv-infected-patients\" class=\"medical medical_review\">Immunizations in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-in-patients-with-primary-immunodeficiency\" class=\"medical medical_review\">Immunizations in patients with primary immunodeficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=international-adoption-immunization-considerations\" class=\"medical medical_review\">International adoption: Immunization considerations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=measles-mumps-and-rubella-immunization-in-infants-children-and-adolescents\" class=\"medical medical_review\">Measles, mumps, and rubella immunization in infants, children, and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=meningococcal-vaccines\" class=\"medical medical_review\">Meningococcal vaccines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccines-for-babies-and-children-age-0-to-6-years-the-basics\" class=\"medical medical_basics\">Patient education: Vaccines for babies and children age 0 to 6 years (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccines-for-children-age-7-to-18-years-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Vaccines for children age 7 to 18 years (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccines-for-children-age-7-to-18-years-the-basics\" class=\"medical medical_basics\">Patient education: Vaccines for children age 7 to 18 years (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccines-for-infants-and-children-age-0-to-6-years-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=why-does-my-child-need-vaccines-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Why does my child need vaccines? (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pneumococcal-streptococcus-pneumoniae-conjugate-vaccines-in-children\" class=\"medical medical_review\">Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=poliovirus-vaccination\" class=\"medical medical_review\">Poliovirus vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-haemophilus-influenzae-type-b-infection\" class=\"medical medical_review\">Prevention of Haemophilus influenzae type b infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-sepsis-in-the-asplenic-patient\" class=\"medical medical_review\">Prevention of sepsis in the asplenic patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rotavirus-vaccines-for-infants\" class=\"medical medical_review\">Rotavirus vaccines for infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seasonal-influenza-in-children-prevention-with-vaccines\" class=\"medical medical_review\">Seasonal influenza in children: Prevention with vaccines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-immunizations-in-children-and-adolescents\" class=\"medical medical_society_guidelines\">Society guideline links: Immunizations in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=standard-childhood-vaccines-parental-hesitancy-or-refusal\" class=\"medical medical_review\">Standard childhood vaccines: Parental hesitancy or refusal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=standard-immunizations-for-nonpregnant-adults\" class=\"medical medical_review\">Standard immunizations for nonpregnant adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccination-for-the-prevention-of-chickenpox-primary-varicella-infection\" class=\"medical medical_review\">Vaccination for the prevention of chickenpox (primary varicella infection)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccinia-virus-as-the-smallpox-vaccine\" class=\"medical medical_review\">Vaccinia virus as the smallpox vaccine</a></li></ul></div></div>","javascript":null}